LABORATORY CORPORATION OF AMERICA HOLDINGS, DBA LABCORP v. LUKE DAVIS, ET AL.
No. 24-304
SUPREME COURT OF THE UNITED STATES
June 5, 2025
605 U. S. ____ (2025)
Per Curiam
NOTICE: This opinion is subject to formal revision before publication in the United States Reports. Readers are requested to notify the Reporter of Decisions, Supreme Court of the United States, Washington, D. C. 20543, pio@supremecourt.gov, of any typographical or other formal errors.
ON WRIT OF CERTIORARI
PER CURIAM.
The writ of certiorari is dismissed as improvidently granted.
It is so ordered.
JUSTICE KAVANAUGH, dissenting.
The Court dismisses the case as improvidently granted and therefore does not decide the question presented: Whether a federal court may certify a damages class pursuant to
The Court presumably dismisses the case because the Court does not want to tackle the threshold mootness question that plaintiffs have raised. In my view, however, plaintiffs’ mootness argument is insubstantial. I would rule that the case is not moot and would decide the question presented.
On the question presented, I would hold that a federal court may not certify a damages class that includes both injured and uninjured members.
I
The facts are fairly straightforward. Labcorp provides diagnostic laboratory services. In 2017, Labcorp introduced self-service kiosks for patients to check in for their appointments. Although the touchscreen kiosks are accessible to most patients, blind and visually impaired patients require assistance. To accommodate those patients who cannot use a kiosk without assistance, or who prefer not to use one, Labcorp maintained and bolstered its front-desk services at patient service centers.
Despite those accommodations, legally blind plaintiffs sued Labcorp in the U. S. District Court for the Central District of California. As relevant here, they claimed that Labcorp‘s new kiosks violated the Americans with Disabilities Act (ADA) and California‘s Unruh Civil Rights Act, which provides for a minimum of $4,000 in state-law statutory damages per violation. See
In May 2022, the District Court certified a damages class under
Labcorp petitioned for an immediate interlocutory appeal under the special interlocutory appellate procedure authorized by
In August 2022, while Labcorp‘s petition for interlocutory appeal was still pending in the Ninth Circuit, the District Court clarified plaintiffs’ class definition. The District Court explained that the class included “[a]ll legally blind individuals who . . ., due to their disability, were unable to use” Labcorp kiosks in California. App. 387. Importantly, the court stated that, “in refining the class definition, this Order does not materially alter the composition of the class or materially change in any manner” the original May class certification order. Id., at 386, n. 10.
In September 2022, the Ninth Circuit granted Labcorp‘s
After the Ninth Circuit denied rehearing en banc, Labcorp sought review in this Court. We granted certiorari to decide whether federal courts may certify a
II
Instead of resolving that important merits question, the Court dismisses this case as improvidently granted. That is presumably because the Court does not want to deal with plaintiffs’ threshold mootness argument. To be clear, the Court does not hold that the case is moot. Rather, the Court simply declines to decide either the threshold mootness question or the important class-action question on which we granted certiorari. Unlike the Court, I would resolve those questions.
In arguing that the case is moot, plaintiffs contend that Labcorp appealed the wrong class-certification order. That is incorrect. Recall the sequence of events. In May 2022, the District Court certified plaintiffs’ damages class, and Labcorp then filed a
The Ninth Circuit subsequently reviewed and ruled on the May certification order. The Ninth Circuit did not treat Labcorp‘s appeal of the May order as
Still, plaintiffs seem to think that the May order was no longer in effect and was superseded by the August order. According to plaintiffs, Labcorp should have somehow appealed the August order. Under Ninth Circuit precedent, however, Labcorp could not have appealed the August order because only orders “that materially change the original certification order” qualify as “appealable under
So to challenge the class definition under Ninth Circuit law, Labcorp could appeal only the May 2022 certification order. Labcorp did so. Labcorp has proceeded reasonably in the District Court, the Court of Appeals, and this Court. There is no barrier to this Court‘s deciding the class-action question presented in the context of reviewing the Ninth Circuit‘s judgment.
III
On the merits, I agree with Labcorp and the United States as amicus curiae: Federal courts may not certify a damages class under
The Ninth Circuit nonetheless approved plaintiffs’ class. Relying on Circuit precedent, the court concluded that
Importantly, the coerced settlements substantially raise the costs of doing business. And companies in turn pass on those costs to consumers in the form of higher prices; to retirement account holders in the form of lower returns; and to workers in the form of lower salaries and lesser benefits. So overbroad and incorrectly certified classes can ultimately harm consumers, retirees, and workers, among others. Simply put, the consequences of overbroad and incorrectly certified damages class actions can be widespread and significant.
*
*
*
I would resolve the question presented and reverse the judgment of the Ninth Circuit. I would hold that federal courts may not certify a damages class pursuant to
